Ashland to Expand Polyplasdone and Polyclar Crosslinked Polyvinylpyrrolidone Production
Ashland Inc. (NYSE: ASH) today announced plans to expand production of Polyplasdone and Polyclar crosslinked polyvinylpyrrolidone at its manufacturing facility in Texas City, Texas in response to strong demand. The company plans to complete the addition of a new PVPP production unit at the site by late 2013, reinforcing Ashland's leading position in the market and enabling the company to continue supporting the growing needs of its pharmaceutical and beverage customers.







